L'hyperuricemie dans l'hypertension arterielte: quelle implication? [Hyperuricemia in hypertension: any clinical implication?]

Détails

ID Serval
serval:BIB_009947C73008
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
L'hyperuricemie dans l'hypertension arterielte: quelle implication? [Hyperuricemia in hypertension: any clinical implication?]
Périodique
Revue Médicale Suisse
Auteur(s)
Deleaval  P., Burnier  M.
ISSN
1660-9379 (Print)
Statut éditorial
Publié
Date de publication
09/2005
Volume
1
Numéro
32
Pages
2072-4, 2077-9
Notes
English Abstract
Journal Article
Review --- Old month value: Sep 14
Résumé
Twenty-five percent of untreated hypertensive patients are hyperuricemic. The causal role of uric acid in the pathogenesis of hypertension has not been clearly demonstrated in humans. An elevated serum uric acid appears to be predictive of the development of hypertension. Serum uric acid has also been considered as a cardiovascular risk factor but this issue is controversial. A high serum uric acid is associated with an increased cardiovascular morbidity and mortality in men. Thus, hyperuricemia in hypertensive patients should be considered as a sign of increased risk leading to a more intensive management of all other risk factors. When managing hypertensive patients with hyperuricemia, physicians should know the impact of antihypertensive drugs on serum uric acid to prevent a further increase in uric acid and the development of gout.
Mots-clé
Antihypertensive Agents/therapeutic use Humans Hypertension/*complications/drug therapy Hyperuricemia/*complications/drug therapy Risk Factors
Pubmed
Création de la notice
25/01/2008 13:55
Dernière modification de la notice
20/08/2019 13:22
Données d'usage